Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03396003
Other study ID # ZIEMER_G6
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 5, 2018
Est. completion date August 1, 2018

Study information

Verified date September 2018
Source Ziemer Ophthalmic Systems AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the Ziemer Ophthalmic Systems AG GALILEI G6 Lens Professional to the Oculus Pentacam® AXL for taking images and measurements of the anterior segment of the eye, including the cornea, pupil, anterior chamber and lens, to assist in determining the power of the intraocular lens for implantation.


Description:

A corneal topographer/biometer named GALILEI G6 Lens Professional was developed by Ziemer Ophthalmic Systems AG for the measurement of anterior segment geometry and axial intraocular distances. The measurement principle of the corneal topographer corresponds to that of the commercially available Galilei G4 Dual Scheimpflug Analyzer, whereas the measurement principle of the biometer is based on low coherence interferometry/reflectometry, which has been widely used and applied clinically by a number of predicate devices.

One complete measurement consists of a corneal topography/ tomography scan followed by three consecutive, axial biometry scans of the anterior segment (cornea and crystalline lens) and three consecutive, axial biometry scans of the retina. The measurement process is continuous but divided into three alignment-click-steps.

Such measurements can be applied to given Intra Ocular Lens (IOL) types and IOL equations, to permit the calculation of recommended IOLs to be implanted during cataract surgery in order to achieve the desired vision correction.

The primary objectives of this clinical study are to: 1) evaluate the inter-device repeatability, inter-operator repeatability and reproducibility of the GALILEI G6 Lens Professional in repeated measurements of anterior segment geometry and axial intraocular distances and, 2) demonstrate substantial equivalence through examining agreement of the GALILEI measurements to those of the predicate device, the Pentacam® AXL.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date August 1, 2018
Est. primary completion date August 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Satisfies one of the subject group categories and the enrollment quota for that category has not been reached:

1. Normal eyes (phakic eyes without cataracts or corneal disease, refraction = -5.5 D or = +5.0 D)

2. Eyes having undergone previous refractive surgery (LASIK or PRK)

3. Eyes with cataracts (LOCS III grading with grades 2-6 in any or all of the posterior subcapsular (P2-P5), nuclear (N2-N5) and cortical (C2-C5), assessed by slit lamp examination; no other known ocular pathology)

4. Eyes with severe myopia (= -6 D according to the American Academy of Ophthalmology)

5. Eyes with severe hyperopia (= +5.25 D according to the American Academy of Ophthalmology)

6. Eyes with previous cross-linking and eyes with advanced keratoconus

- Manifest refraction sSpherical eEquivalent Refraction (MRSER) between -10dpt and +10dpt as measured by cycloplegic autorefraction assessed less than 12 months prior to enrollment

- Best corrected visual acuity (BCVA) of LogMAR 0.2 or better

Exclusion Criteria:

- Strabismus, nystagmus, amblyopia, anisometropia (difference in MRSER>3D)

- Angle closure glaucoma

- Seizure disorder, brain damage, Down Syndrome, Trisomy 13 or 18, Cerebral Palsy or other serious ophthalmic or central nervous system disorders

- Severe dry eye

- Severe corneal scarring

- Inability to hold gaze

- Inability to see fixation target

Study Design


Related Conditions & MeSH terms


Intervention

Device:
GALILEI G6 Lens Professional
Eight measurements of the eye using the GALILEI G6 Lens Professional will be taken using two different devices and 2 different operators
Oculus Pentacam AXL
A single measurement of the eye will be taken using the Oculus Pentacam AXL

Locations

Country Name City State
Switzerland Ziemer Ophthalmic Systems AG Port

Sponsors (1)

Lead Sponsor Collaborator
Ziemer Ophthalmic Systems AG

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Axial Length (AL) Measurement in millimeters (mm) Repeatability and reproducability across and between evaluations One day
Primary Central Corneal Thickness (CCT) Measurement in micrometers (µm) Repeatability and reproducability across and between evaluations One day
Primary Radius Flat Meridian (R flat) Measurement in millimeters (mm) Repeatability and reproducability across and between evaluations One day
Primary Radius Steep Meridian (R steep) Measurement in millimeters (mm) Repeatability and reproducability across and between evaluations One day
Primary Mean Radius (Rm) Measurement in millimeters (mm) Repeatability and reproducability across and between evaluations One day
Primary Corneal Cylinder Measurement in diopters (D) Repeatability and reproducability across and between evaluations One day
Primary Corneal Cylinder Axis (A flat) Measurement in degrees Repeatability and reproducability across and between evaluations One day
Primary Anterior Chamber Depth (ACD) Measurement in millimeters (mm) Repeatability and reproducability across and between evaluations One day
Primary Horizontal White-to-White distance (WtW) Measurement in millimeters (mm). Repeatability and reproducability across and between evaluations One day
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A